Klinikum Würzburg Mitte gGmbH Standort Missioklinik

Würzburg 97074

1 studies enrolling now · 5 studies all time

What they study most

Carcinoma, Non-small-Cell Lung, Chronic Thromboembolic Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction, Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH), Sarcoidosis-associated Pulmonary Hypertension

Studies at this site

• A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer — Recruiting now
• Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) — Completed
• A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease — Completed
• A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment — Stopped early
• A Study in Participants With Sarcoidosis-associated Pulmonary Hypertension (SAPH) to Assess the Efficacy and Safety of Oral Selexipag — Stopped early